Leqvio (inclisiran) - Novartis
Praluent (alirocumab) - Sanofi, Regeneron
Repatha (evolocumab) - Amgen, Astellas
Junshida (ongericimab) - Shanghai Junshi Biosci
http://www.ncbi.nlm.nih.gov/pubmed/40918505
 
Bohan Luo; Han Luo; Zhuang Sun
 
Sep 8, 2025
 
Next